
Pancreatic cancer is often fatal, but a molecular test that can accurately distinguish benign cysts from those that could become cancerous may be a key to saving lives. Researchers tested the technology — called PancreaSeq — to see if it could work in a clinical setting and found success. “Based on the results of this… read on > read on >